Cidara Therapeutics
San Diego, US · Founded 2012 · Delaware corporation · 44,945 employees on LinkedIn · 8 known investors
Pharmaceutical company developing medicines and vaccines for patient health and treatment. Operating for over 130 years with focus on clinical research and drug development.
Founders & leadership
Cidara Therapeutics was founded in 2012 by Jeffrey Stein and Kevin Judice.
JS
Jeffrey SteinCo-founder
KJ
Kevin JudiceinCo-founder
KF
Kevin ForrestExecutive
DT
Dirk ThyeExecutive
KB
Ken BartizalinExecutive
PD
Paul DaruwalainExecutive
Board
SE
SR
NK
PH
DB
Dan BurgessBoard director
TS
Ted SchroederBoard director
Investors · 8
5AM VenturesBoston · $100K – $4Mvia Scott Rocklage · board
Aisling CapitalNew York
Bain Capital Life SciencesBoston
Frazier Life SciencesPalo Altovia Patrick Heron · board
RA CapitalBoston
Vivo CapitalPalo Alto · $10M – $50M
Canaan PartnersreportedStamford · $500K – $20Mvia Nina Kjellson · board
Venrock Healthcare Capital PartnersreportedNew York
Reported raises · per SEC filings
Form D private placements$349.1M disclosed across 7 rounds · 2014–2024
▶$240MraisedMay 2024 · 7 investors · BiotechnologyRule 506(b)
▶$240MraisedMay 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carin Canale-TheakstonDirector
- Theodore R. SchroederDirector
- Daniel D. BurgessDirector
- Laura Tadvalkar, Ph.D.Director
- Taylor Sandison, M.D.Executive Officer
- Leslie Tari, Ph.D.Executive Officer
- Preetam Shah, Ph.D.Executive Officer
- Bonnie Bassler, Ph.D.Director
- James Merson, Ph.D.Director
- Ryan SpencerDirector
- Shane WardExecutive Officer
- Jeffrey Stein, Ph.D.Executive Officer, Director
- Offering amount
- $240M
- Amount sold
- $240M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedSep 2019 · 1 investors · BiotechnologyRule 506(b)
▶$9MraisedSep 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey SteinExecutive Officer, Director
- Daniel D BurgessDirector
- Theodore R SchroederDirector
- David GollaherDirector
- Timothy FransonDirector
- Jessica OienExecutive Officer
- Taylor SandisonExecutive Officer
- Chrysa MineoDirector
- James LevineExecutive Officer
- Neil AbdollahianExecutive Officer
- Paul DaruwalaExecutive Officer
- Offering amount
- $9M
- Amount sold
- $9M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedMay 2018 · 16 investors · BiotechnologyRule 506(b)
▶$1.6MraisedMay 2018 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Taylor SandisonExecutive Officer
- Robert J PerezDirector
- Theodore R SchroederDirector
- Matthew OnaitisExecutive Officer
- Jeffrey SteinExecutive Officer, Director
- Timothy R FransonDirector
- Daniel D BurgessDirector
- Scott M RocklageDirector
- Chrysa MineoDirector
- Offering amount
- $1.9M
- Amount sold
- $1.6M
- Sales commissions
- $1.9M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.2MraisedOct 2017 · 16 investors · BiotechnologyRule 506(b)
▶$20.2MraisedOct 2017 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel D BurgessDirector
- Theodore R SchroederDirector
- Timothy R FransonDirector
- Kevin ForrestExecutive Officer
- Ken BartizalExecutive Officer
- Matthew OnaitisExecutive Officer
- Jeffrey SteinExecutive Officer, Director
- Taylor SandisonExecutive Officer
- Neil AbdollahianExecutive Officer
- Robert J PerezDirector
- Paul DaruwalaExecutive Officer
- Scott M RocklageDirector
- Offering amount
- $20.2M
- Amount sold
- $20.2M
- Finders' fees
- $1.1M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$42MraisedFeb 2015 · 19 investors · BiotechnologyRule 506(b)
▶$42MraisedFeb 2015 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey SteinExecutive Officer, Director
- Steve ElmsDirector
- Dan BurgessDirector
- Scott RocklageDirector
- Ted SchroederDirector
- Kevin ForrestExecutive Officer
- Dirk ThyeExecutive Officer
- Ken BartizalExecutive Officer
- Kevin JudiceDirector
- Paul DaruwalaExecutive Officer
- Nina KjellsonDirector
- Patrick HeronDirector
- Offering amount
- $42M
- Amount sold
- $42M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$30.3MraisedJun 2014 · 8 investors · BiotechnologyRule 506(b)
▶$30.3MraisedJun 2014 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey SteinExecutive Officer, Director
- Kevin ForrestExecutive Officer
- Nina KjellsonDirector
- Patrick HeronDirector
- Scott RocklageDirector
- Kevin JudiceExecutive Officer, Director
- Ted SchroederDirector
- Dan BurgessDirector
- Steve ElmsDirector
- Offering amount
- $42.7M
- Amount sold
- $30.3M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$6MraisedJun 2014 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedJun 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick HeronDirector
- Ted SchroederDirector
- Dan BurgessDirector
- Kevin ForrestExecutive Officer
- Nina KjellsonDirector
- Jeffrey SteinExecutive Officer, Director
- Steve ElmsDirector
- Kevin JudiceExecutive Officer, Director
- Scott RocklageDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Merck Stock Jumps on Phase 3 Cancer Vaccine Win as Keytruda Risk Easestradingkey.com · Aug 2026Frequently asked questions
- What does Cidara Therapeutics do?
- Pharmaceutical company developing medicines and vaccines for patient health and treatment. Operating for over 130 years with focus on clinical research and drug development.
- Who founded Cidara Therapeutics?
- Cidara Therapeutics was founded by Jeffrey Stein, Kevin Judice in 2012.
- Who are Cidara Therapeutics's investors?
- Cidara Therapeutics's investors include 5AM Ventures, Aisling Capital, Bain Capital Life Sciences, Frazier Life Sciences, RA Capital, Vivo Capital, Canaan Partners, Venrock Healthcare Capital Partners.
- How much funding has Cidara Therapeutics raised?
- Cidara Therapeutics has disclosed $349.1M raised across 7 rounds.
- Where is Cidara Therapeutics headquartered?
- Cidara Therapeutics is headquartered in San Diego, US.